Operating Income Summary of Novartis AG

Novartis AG's latest annual operating income in 2023 was 9.76 Billion USD , up 6.22% from previous year.
Novartis AG's latest quarterly operating income in 2024 Q3 was 3.62 Billion USD , down -8.22% from previous quarter.
Novartis AG reported an annual operating income of 9.19 Billion USD in 2022, down -21.32% from previous year.
Novartis AG reported an annual operating income of 11.68 Billion USD in 2021, up 15.14% from previous year.
Novartis AG reported a quarterly operating income of 3.51 Billion USD for 2024 Q1, up 36.22% from previous quarter.
Novartis AG reported a quarterly operating income of 3.95 Billion USD for 2024 Q2, up 12.35% from previous quarter.

Annual Operating Income Chart of Novartis AG (2023 - 1998)

Historical Annual Operating Income of Novartis AG (2023 - 1998)

Year	Operating Income	Operating Income Growth
2023	9.76 Billion USD	6.22%
2022	9.19 Billion USD	-21.32%
2021	11.68 Billion USD	15.14%
2020	10.15 Billion USD	11.73%
2019	9.08 Billion USD	11.23%
2018	8.16 Billion USD	-5.33%
2017	8.62 Billion USD	4.37%
2016	8.26 Billion USD	-7.9%
2015	8.97 Billion USD	-19.05%
2014	11.08 Billion USD	1.64%
2013	10.91 Billion USD	-5.22%
2012	11.51 Billion USD	4.66%
2011	10.99 Billion USD	-4.58%
2010	11.52 Billion USD	15.47%
2009	9.98 Billion USD	11.36%
2008	8.96 Billion USD	32.19%
2007	6.78 Billion USD	-14.69%
2006	7.94 Billion USD	15.12%
2005	6.9 Billion USD	5.6%
2004	6.53 Billion USD	11.04%
2003	5.88 Billion USD	4.53%
2002	5.63 Billion USD	28.28%
2001	4.39 Billion USD	-8.61%
2000	4.8 Billion USD	4.07%
1999	4.61 Billion USD	-13.62%
1998	5.34 Billion USD	0.0%

Year	Operating Income	Operating Income Growth
2024 Q3	3.62 Billion USD	-8.22%
2024 Q1	3.51 Billion USD	36.22%
2024 Q2	3.95 Billion USD	12.35%
2023 Q3	1.76 Billion USD	-39.66%
2023 Q4	2.58 Billion USD	46.54%
2023 FY	9.76 Billion USD	6.22%
2023 Q1	2.85 Billion USD	46.54%
2023 Q2	2.92 Billion USD	2.24%
2022 Q3	2.16 Billion USD	-2.69%
2022 FY	9.19 Billion USD	-21.32%
2022 Q4	1.94 Billion USD	-10.1%
2022 Q1	2.85 Billion USD	11.32%
2022 Q2	2.22 Billion USD	-21.88%
2021 Q4	2.56 Billion USD	-20.75%
2021 Q2	3.47 Billion USD	44.06%
2021 FY	11.68 Billion USD	15.14%
2021 Q1	2.41 Billion USD	-8.66%
2021 Q3	3.23 Billion USD	-7.07%
2020 Q1	2.74 Billion USD	50.52%
2020 Q3	2.41 Billion USD	2.55%
2020 Q2	2.35 Billion USD	-14.29%
2020 Q4	2.64 Billion USD	9.62%
2020 FY	10.15 Billion USD	11.73%
2019 Q4	1.82 Billion USD	-22.69%
2019 Q1	2.24 Billion USD	72.59%
2019 Q3	2.35 Billion USD	-11.45%
2019 Q2	2.66 Billion USD	18.78%
2019 FY	9.08 Billion USD	11.23%
2018 Q4	1.29 Billion USD	-41.98%
2018 FY	8.16 Billion USD	-5.33%
2018 Q2	2.48 Billion USD	1.51%
2018 Q1	2.44 Billion USD	18.21%
2018 Q3	2.23 Billion USD	-9.86%
2017 Q2	2.28 Billion USD	18.63%
2017 Q1	1.92 Billion USD	32.1%
2017 Q3	2.35 Billion USD	3.38%
2017 Q4	2.07 Billion USD	-12.18%
2017 FY	8.62 Billion USD	4.37%
2016 Q4	1.45 Billion USD	-35.87%
2016 FY	8.26 Billion USD	-7.9%
2016 Q1	2.45 Billion USD	46.15%
2016 Q3	2.26 Billion USD	8.41%
2016 Q2	2.09 Billion USD	-14.61%
2015 Q2	2.28 Billion USD	-18.1%
2015 FY	8.97 Billion USD	-19.05%
2015 Q4	1.67 Billion USD	-24.93%
2015 Q3	2.23 Billion USD	-2.06%
2015 Q1	2.78 Billion USD	18.46%
2014 Q4	2.35 Billion USD	-14.17%
2014 Q1	3.48 Billion USD	47.03%
2014 FY	11.08 Billion USD	1.64%
2014 Q3	2.73 Billion USD	-13.98%
2014 Q2	3.18 Billion USD	-8.74%
2013 Q3	2.67 Billion USD	-10.07%
2013 Q2	2.97 Billion USD	2.56%
2013 FY	10.91 Billion USD	-5.22%
2013 Q4	2.37 Billion USD	-11.16%
2013 Q1	2.89 Billion USD	16.73%
2012 Q1	2.81 Billion USD	113.74%
2012 Q2	3.18 Billion USD	13.25%
2012 Q3	3.02 Billion USD	-5.05%
2012 FY	11.51 Billion USD	4.66%
2012 Q4	2.48 Billion USD	-18.04%
2011 FY	10.99 Billion USD	-4.58%
2011 Q1	3.4 Billion USD	38.14%
2011 Q2	3.32 Billion USD	-2.52%
2011 Q4	1.31 Billion USD	-55.37%
2011 Q3	2.95 Billion USD	-11.17%
2010 Q1	3.51 Billion USD	33.14%
2010 FY	11.52 Billion USD	15.47%
2010 Q4	2.46 Billion USD	-4.64%
2010 Q3	2.58 Billion USD	-12.63%
2010 Q2	2.96 Billion USD	-15.67%
2009 Q3	2.63 Billion USD	11.42%
2009 Q4	2.63 Billion USD	0.11%
2009 Q2	2.36 Billion USD	0.72%
2009 Q1	2.34 Billion USD	39.7%
2009 FY	9.98 Billion USD	11.36%
2008 Q2	2.46 Billion USD	-1.09%
2008 Q4	1.68 Billion USD	-28.05%
2008 Q3	2.33 Billion USD	-5.12%
2008 FY	8.96 Billion USD	32.19%
2008 Q1	2.48 Billion USD	710.42%
2007 Q4	307 Million USD	-84.97%
2007 Q2	2.22 Billion USD	-8.04%
2007 Q1	2.42 Billion USD	51.59%
2007 FY	6.78 Billion USD	-14.69%
2007 Q3	2.04 Billion USD	-8.39%
2006 Q3	2.08 Billion USD	1.36%
2006 FY	7.94 Billion USD	15.12%
2006 Q4	1.59 Billion USD	-23.42%
2006 Q2	2.06 Billion USD	-6.45%
2006 Q1	2.2 Billion USD	47.98%
2005 FY	6.9 Billion USD	5.6%
2005 Q1	1.68 Billion USD	9.52%
2005 Q2	1.84 Billion USD	10.06%
2005 Q3	1.88 Billion USD	2.11%
2005 Q4	1.48 Billion USD	-21.19%
2004 FY	6.53 Billion USD	11.04%
2004 Q2	1.79 Billion USD	20.08%
2004 Q3	1.71 Billion USD	-4.29%
2004 Q4	1.53 Billion USD	-10.66%
2004 Q1	1.49 Billion USD	-6.97%
2003 Q1	1.35 Billion USD	-28.44%
2003 Q3	1.46 Billion USD	0.41%
2003 Q4	1.6 Billion USD	9.33%
2003 FY	5.88 Billion USD	4.53%
2003 Q2	1.46 Billion USD	8.29%
2002 Q4	1.88 Billion USD	52.01%
2002 Q3	1.24 Billion USD	-13.87%
2002 Q2	1.44 Billion USD	-70.32%
2002 Q1	4.85 Billion USD	149.55%
2002 FY	5.63 Billion USD	28.28%
2001 Q1	4.44 Billion USD	140.13%
2001 FY	4.39 Billion USD	-8.61%
2001 Q4	-9.8 Billion USD	-275.84%
2001 Q3	5.57 Billion USD	474.85%
2001 Q2	970 Million USD	-78.15%
2000 Q2	1.37 Billion USD	-75.9%
2000 Q3	4.88 Billion USD	255.5%
2000 Q4	-11.06 Billion USD	-326.7%
2000 Q1	5.69 Billion USD	0.0%
2000 FY	4.8 Billion USD	4.07%
1999 FY	4.61 Billion USD	-13.62%
1998 FY	5.34 Billion USD	0.0%

Peer Operating Income Comparison of Novartis AG

Name	Operating Income	Operating Income Difference
AstraZeneca PLC	8.19 Billion USD	-19.236%
Bristol-Myers Squibb Company PFD CONV 2	17.24 Billion USD	43.342%
CSPC Pharmaceutical Group Limited	7.01 Billion USD	-39.239%
Clarus Therapeutics Holdings, Inc.	-39.73 Million USD	24687.234%
PT Kalbe Farma Tbk.	3625.13 Billion USD	99.731%

Global Stocks Search

Novartis AG (NVSEF)

Operating Income Summary of Novartis AG

Annual Operating Income Chart of Novartis AG (2023 - 1998)

Historical Annual Operating Income of Novartis AG (2023 - 1998)

Peer Operating Income Comparison of Novartis AG